Fluticasone
From Wikipedia, the free encyclopedia
|
Fluticasone
|
|
| Systematic (IUPAC) name | |
| S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)- 6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo- 6,7,8,11,12,14,15,16-octahydrocyclopenta[a] phenanthrene-17-carbothioate |
|
| Identifiers | |
| CAS number | 80474-14-2 (propionate) |
| ATC code | D07 & D07 (topical) |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| Chemical data | |
| Formula | C22H27F3O4S |
| Mol. mass | 444.508 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | 0.51% (Intranasal) |
| Protein binding | 91% |
| Metabolism | Intranasal Hepatic (CYP3A4-mediated) |
| Half life | 10 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
C for Intranasal and Inhaled |
| Legal status | |
| Routes | Intranasal, Inhaled, Topical Cream or Ointment |
Fluticasone is a synthetic corticosteroid.
Both the furoate and propionate forms are used as topical anti-inflammatories:
[edit] See also
|
|||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||

